A 41-year-old woman comes into the consultation room, sits down, pulls down her lower eyelid with her index finger, and says, "I want my under-eyes fixed. I look exhausted all the time, even when I am not. Someone told me filler would do it." She has been told by an injector somewhere else that she is a candidate for tear trough filler. She is not. The hollow she is pointing to is partly genuine volume loss, partly a fat-pad herniation that filler will worsen, partly skin laxity that no filler can address, and partly a pigmentation pattern that needs a completely different intervention. If I treat what she is asking for, I will make her look worse — and I will be the second injector in this town to do so on this patient.
Tear trough filler is one of the most technically unforgiving injections in aesthetics. The undereye region has thin skin, complex anatomy, low tolerance for product migration, and a long memory for mistakes. When it goes well, it is genuinely transformative. When it goes badly, it produces a cosmetic problem that the patient lives with for nine to eighteen months — sometimes longer if the product was the wrong choice — and that takes hyaluronidase, multiple visits, and sometimes a referral to oculoplastics to correct. This article is the consultation I would give you in the chair, in the order I would give it.
The anatomy that makes this injection different
The tear trough is not a wrinkle. It is a depression that sits over the orbital rim, formed by the boundary between the orbicularis oculi muscle, the orbital septum, and the cheek fat compartments below. The skin in this region is the thinnest on the face — about half a millimeter — and sits directly over a network of vasculature that includes the angular artery and its branches. The infraorbital artery exits the infraorbital foramen approximately 1 cm below the orbital rim in the midpupillary line, and getting filler near it carries real consequences.
The relevant complications that come from misjudging this anatomy are not theoretical. They include vascular occlusion (filler entering an artery and blocking blood flow, which can cause skin necrosis or, in the worst case, blindness from retrograde flow into the ophthalmic artery), Tyndall effect (a bluish discoloration that occurs when hyaluronic acid filler is placed too superficially in thin skin), persistent malar edema (chronic puffiness from filler placed in or above the orbicularis retaining ligament that traps lymphatic fluid), product migration into adjacent compartments, and lumpiness that is visible in motion and in certain lighting.
Vascular occlusion is the emergency. If it happens during the injection, the response window is short — hyaluronidase needs to flood the area within hours, and ideally minutes. Any provider injecting in this region needs hyaluronidase on the shelf, an aspiration technique that minimizes intravascular injection risk, and the training to recognize and respond to the early signs (severe pain disproportionate to the injection, blanching, livedo pattern in the skin). If you are evaluating a provider, ask them what they would do if they suspected vascular occlusion. The answer should be specific and immediate.
Why most "tear trough" complaints are not tear trough problems
When a patient points at the area under her eye and says she does not like how it looks, the underlying anatomy is rarely a single thing. I see five distinct contributing factors, and the right intervention depends on which combination is driving the appearance.
True tear trough volume loss. The genuine indication for filler — a hollow that runs from the medial canthus diagonally down toward the cheek, with no significant fat-pad herniation above it. This is the patient who actually benefits from a small, deep, conservative placement of hyaluronic acid filler against the orbital rim.
Pseudo-herniation of orbital fat. A bag of fat that has pushed forward through a weakened orbital septum. Adding filler below it makes the bag look bigger by emphasizing the contrast. The right intervention here is often surgical — lower lid blepharoplasty — or in some cases, energy-based skin tightening. Filler is the wrong answer.
Skin laxity and crepiness. Thin, lax, finely wrinkled skin under the eye. Filler underneath does nothing for the surface texture and may make the laxity more apparent. The relevant interventions are microneedling, fractional CO2 laser, conservative chemical peels, and sometimes a vampire facial using PRP, depending on what the skin will tolerate.
Pigmentation. True dark circles from melanin deposition (common in patients with deeper Fitzpatrick skin types) or hemosiderin staining from chronic vascular leak. Filler does not address the color — it addresses the shadow. If the dark circles are pigment, the patient needs a brightening protocol, sun protection, and sometimes a VI Peel or AquaFirme facial, not a syringe.
Midface volume loss. The most underrecognized contributor. Volume loss in the cheek fat compartments creates the appearance of a tear trough hollow by allowing the lower lid to look longer and emptier than it is. The right injection point in these patients is often the cheek, not the under-eye. Restoring midface volume frequently softens or eliminates the tear trough appearance entirely, with no risk of the under-eye complications.
A real consultation sorts these factors out before any product comes near the face. If a provider does not assess all five, they are not doing a real consultation.
How I evaluate a patient for tear trough filler
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
When a patient sits down asking about under-eye filler, my workflow is consistent. I look at the face in good lighting, with no makeup, both static and animated. I have the patient smile, frown, look up, look down, and turn side to side, because the under-eye area changes shape dramatically with motion and the ideal injection plan accounts for those dynamics.
I assess skin quality — thickness, elasticity, pigmentation, fine lines, vascularity. I assess the orbital rim and tear trough depth by direct palpation. I assess the cheek fat compartments for volume and projection. I look for fat-pad herniation by having the patient look up while I apply gentle pressure on the globe, which makes pseudo-herniation more visible. I assess the lower lid for laxity using a snap-back test. I look at the malar region for festoons or chronic edema, both of which are relative contraindications to under-eye filler because filler in this setting reliably worsens them.
I take the history. Prior fillers in this region — what product, how long ago, and what happened. Prior dissolving with hyaluronidase. Allergies, particularly to lidocaine. Bleeding tendency or anticoagulant use. Recent dental work or upcoming dental work (filler near the infraorbital region close to dental procedures has been associated with biofilm-related complications). History of cold sores in the area. Current skincare regimen, particularly retinoid use.
Then I tell the patient what I think. Sometimes that is "yes, you are a good candidate, here is the conservative plan." Sometimes that is "the right answer for you is not filler — it is something else, and here is why." I would rather lose the visit than give a patient a treatment that will make her unhappy at the six-week mark.
What I will and will not do at the procedure itself
When the assessment supports a dermal filler treatment for the tear trough, I use a small volume — typically 0.3 to 0.5 mL per side total, sometimes less. I use a low-G-prime hyaluronic acid product specifically formulated for thin tissue, not a thicker filler designed for cheek or chin augmentation. I prefer cannula technique in this region because cannulas reduce — not eliminate — the risk of intravascular injection. I place product deep, against the periosteum at the orbital rim, in small aliquots, with frequent reassessment.
I do not stack a tear trough filler on top of a recent fat-pad change without at least an eight-week wait. I do not chase a result that the anatomy will not support. I do not inject through a known active acne lesion or herpetic lesion in the area. I have hyaluronidase, lidocaine, and emergency response protocols on the shelf and within reach, every time.
I see the patient back at two weeks. If the result needs additional product, that is when it goes in. The conservative-first approach is what produces the natural, undetectable result that this region demands. Overcorrection is the failure mode I see most often when I evaluate filler done elsewhere.
When a patient is unhappy with prior tear trough work
I see this often enough that it deserves its own paragraph. Patients arrive frustrated, sometimes embarrassed, with persistent under-eye puffiness, blue-gray discoloration, asymmetry, or the sense that their face does not look like theirs anymore. The first conversation is honest assessment of what was done, where, with what likely product, and how to undo it.
Hyaluronidase is the answer for hyaluronic acid filler that is in the wrong place or in the wrong amount. The dissolution is usually complete within 24 to 48 hours, sometimes requires a second visit, and almost always requires a wait of several weeks before any new treatment is considered. The patient needs to see what her face looks like at baseline before deciding what, if anything, to do next.
If the original product was not hyaluronic acid — calcium hydroxylapatite or poly-L-lactic acid, both of which I would not use in this region but some injectors do — the timeline is much longer. Those products are not dissolvable and the patient lives with the result until the body resorbs it, which can take years.
The concrete next step
If you are considering under-eye filler, the most important thing you can do is sit down with a provider who will tell you whether you are actually a candidate. Bring a written list of what bothers you about the area, ideally with photos of yourself in your normal lighting, both with and without makeup. If you have had filler in this region before, bring documentation of what was used and when.
Book online at the Columbus or Warner Robins location for an aesthetic consultation. The first visit is assessment and conversation — not injection. If the right answer for you is a dermal filler treatment, we will plan it conservatively and follow up in two weeks. If the right answer is something else — surgical referral, skin resurfacing, midface filler instead of under-eye filler, or no intervention at all — we will tell you that, and we will not put product into your face that does not belong there. That is the only way under-eye work goes well.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.